Clinical Factors Affecting the Response to Osimertinib in Non-Small Cell Lung Cancer Patients with An Acquired Epidermal Growth Factor Receptor T790M Mutation: A Long-Term Survival Analysis

Chen, Y; Wang, SY; Zhang, B; Zhao, YM; Zhang, LL; Hu, MJ; Zhang, W; Han, BH

Zhang, W; Han, BH (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, Shanghai 230032, Peoples R China.

TARGETED ONCOLOGY, 2020; 15 (3): 337

Abstract

Background Osimertinib is a standard therapy for advanced non-small cell lung cancer (NSCLC) patients with an acquired epidermal growth factor recepto......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索